Twilio Available For Sale Securities Debt Securities Current increased by 0.9% to $1.80B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 8.9%, from $1.98B to $1.80B. Over 5 years (FY 2020 to FY 2025), Available For Sale Securities Debt Securities Current shows a downward trend with a -3.2% CAGR.
An increase suggests higher liquidity and a conservative cash management strategy, while a decrease may indicate cash deployment for operations or acquisitions.
This represents the portion of a company's investment portfolio consisting of debt securities that are expected to be so...
Common among large-cap pharmaceutical firms maintaining significant cash reserves for R&D and M&A activities.
current_assets_available_for_sale_securities_debt_securi_87ec82| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.13B | $3.90B | $3.88B | $3.61B | $3.59B | $3.58B | $3.50B | $3.31B | $3.01B | $3.18B | $3.36B | $3.15B | $2.36B | $2.11B | $1.96B | $1.98B | $1.57B | $1.72B | $1.79B | $1.80B |
| QoQ Change | — | -5.5% | -0.5% | -7.0% | -0.4% | -0.5% | -2.0% | -5.5% | -9.1% | +5.7% | +5.6% | -6.0% | -25.1% | -10.5% | -7.2% | +0.9% | -20.6% | +9.6% | +3.7% | +0.9% |
| YoY Change | — | — | — | — | -12.9% | -8.2% | -9.7% | -8.2% | -16.3% | -11.1% | -4.2% | -4.7% | -21.5% | -33.5% | -41.5% | -37.2% | -33.4% | -18.5% | -8.9% | -8.9% |